Center Laboratories (4123) - Total Liabilities
Based on the latest financial reports, Center Laboratories (4123) has total liabilities worth NT$6.17 Billion TWD (≈ $194.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Center Laboratories - Total Liabilities Trend (2006–2024)
This chart illustrates how Center Laboratories's total liabilities have evolved over time, based on quarterly financial data. See Center Laboratories (4123) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Center Laboratories Competitors by Total Liabilities
The table below lists competitors of Center Laboratories ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xvivo Perfusion AB
ST:XVIVO
|
Sweden | Skr299.60 Million |
|
Kyobo Securiti
KO:030610
|
Korea | ₩17.15 Trillion |
|
Decai Decoration Co Ltd
SHG:605287
|
China | CN¥9.25 Billion |
|
Patriot Battery Metals Inc
AU:PMT
|
Australia | AU$37.43 Million |
|
Lenzing Aktiengesellschaft
VI:LNZ
|
Austria | €3.31 Billion |
|
Janux Therapeutics Inc
NASDAQ:JANX
|
USA | $86.69 Million |
|
Hnac Technology Co Ltd
SHE:300490
|
China | CN¥4.83 Billion |
|
Myers Industries Inc
NYSE:MYE
|
USA | $547.86 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down Center Laboratories's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Center Laboratories (4123) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Center Laboratories's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Center Laboratories (2006–2024)
The table below shows the annual total liabilities of Center Laboratories from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$7.48 Billion ≈ $235.75 Million |
+10.27% |
| 2023-12-31 | NT$6.79 Billion ≈ $213.79 Million |
+14.33% |
| 2022-12-31 | NT$5.94 Billion ≈ $186.99 Million |
-36.51% |
| 2021-12-31 | NT$9.35 Billion ≈ $294.54 Million |
+29.26% |
| 2020-12-31 | NT$7.23 Billion ≈ $227.87 Million |
-2.35% |
| 2019-12-31 | NT$7.41 Billion ≈ $233.36 Million |
+50.87% |
| 2018-12-31 | NT$4.91 Billion ≈ $154.68 Million |
-77.09% |
| 2017-12-31 | NT$21.43 Billion ≈ $675.18 Million |
+47.47% |
| 2016-12-31 | NT$14.53 Billion ≈ $457.84 Million |
+11.54% |
| 2015-12-31 | NT$13.03 Billion ≈ $410.49 Million |
+386.21% |
| 2014-12-31 | NT$2.68 Billion ≈ $84.43 Million |
+492.94% |
| 2013-12-31 | NT$451.94 Million ≈ $14.24 Million |
-25.60% |
| 2012-12-31 | NT$607.42 Million ≈ $19.14 Million |
+52.61% |
| 2011-12-31 | NT$398.01 Million ≈ $12.54 Million |
+48.10% |
| 2010-12-31 | NT$268.74 Million ≈ $8.47 Million |
-11.06% |
| 2009-12-31 | NT$302.16 Million ≈ $9.52 Million |
-31.80% |
| 2008-12-31 | NT$443.09 Million ≈ $13.96 Million |
+149.39% |
| 2007-12-31 | NT$177.67 Million ≈ $5.60 Million |
-20.15% |
| 2006-12-31 | NT$222.51 Million ≈ $7.01 Million |
-- |
About Center Laboratories
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antituss… Read more